Stroke

Till the end of 2016, our department has treated 1097 patients of stroke (including cerebral hemorrhage and cerebral thrombosis) sequela. Among these patients, the longest onset time is 19 years, and the shortest is one month (only few patients). At present, our department is trying to apply stem cell transplantation to treat cerebrovasucular disease sequela in acute stage and recovery stage. The animal experiments confirmed that using stem cell transplantation in acute stage and recovery stage can save a large amount of nerve cells around the cerebral injured area (ischemic penumbra), and restore their neurological function, hence reduce the disability rate and handicapped degree. Once the patient passed recovery stage and get into sequela stage, the best treating time is gone, and nerve cells around ischemic penumbra start dying, then some hard and dense glial scars which obstruct nerve regeneration will be formed around the injured area. It will be much more difficult to treat the disease then. The improvement rate of stroke (including cerebral hemorrhage and cerebral thrombosis) sequela is 88%. Many patients have a certain degree of improvement even when they were in hospital, and the improvement shows on：

* Improvements after stem cell treatment vary from patient to patient and we do not make any guarantees.